Goldman, Sachs

Goldman Sachs Upgrades Coinbase, Spotlighting a Strategic Pivot

06.01.2026 - 22:04:04

Coinbase US19260Q1076

Shares of cryptocurrency exchange Coinbase Global, Inc. advanced sharply this week, propelled by a significant analyst upgrade from Wall Street giant Goldman Sachs. The firm's stock gained approximately 8% following the revised rating, which shifted from "Neutral" to "Buy" and accompanied a raised price target from $294 to $303. This new target suggests an upside potential of about 18% from recent trading levels.

The core rationale behind Goldman's bullish stance centers on Coinbase's evolving business model. Analyst James Yaro emphasized the company's successful diversification beyond its core trading operations. Revenue streams from infrastructure services—including custody, staking, and subscription products—now constitute roughly 40% of total revenue. This marks a dramatic shift from five years ago, when such services contributed less than 5%.

Goldman Sachs views this transformation as a critical strategic move. It reduces Coinbase's dependence on highly volatile transaction fees and better positions the firm to capitalize on broader financial trends, such as the tokenization of real-world assets.

Contrasting Views on Trading Volatility

However, the market outlook is not uniformly positive, highlighting the dual narrative surrounding the stock. While maintaining a "Buy" recommendation, analysts at Rosenblatt Securities simultaneously slashed their price target for Coinbase from $470 to $325. This substantial reduction reflects concerns over trading activity, which has cooled significantly after a record month in October 2025.

Rosenblatt cut its estimate for fourth-quarter 2025 trading volume by 35%, down to $207 billion. This divergence in analyst perspectives underscores Coinbase's current balancing act: its promising long-term infrastructure story is progressing, yet its near-term financial performance remains tightly coupled to the unpredictable crypto trading cycle.

Should investors sell immediately? Or is it worth buying Coinbase?

CEO Armstrong Charts the Course for an "Everything Exchange"

Amid this analytical debate, Coinbase CEO Brian Armstrong recently reaffirmed the company's ambitious roadmap. On social media, he outlined a vision for 2026 centered on creating an "Everything Exchange." This platform aims to integrate traditional financial assets like stocks alongside cryptocurrencies, stablecoins, and its Base layer-2 network. The goal is to build a comprehensive financial ecosystem that fosters user loyalty and competes directly with conventional brokerage services.

Expansion efforts, however, face international hurdles. The company recently had its access blocked in the Philippines and will discontinue trading for USDC-ARS pairs in Argentina by the end of January.

Awaiting Clarity from Quarterly Results

Investor attention now turns to Coinbase's upcoming Q4 2025 earnings report, which will provide concrete data on the extent of the recent trading volume softness. From a technical analysis perspective, the $285 price level is seen as a key resistance point; a sustained breakout above it could signal a stronger bullish trend.

The central question for the market is whether the growth in high-margin, recurring infrastructure revenue can accelerate rapidly enough to offset the inherent volatility of the trading business. The answer will likely determine the stock's trajectory in the coming quarters.

Ad

Coinbase Stock: Buy or Sell?! New Coinbase Analysis from January 6 delivers the answer:

The latest Coinbase figures speak for themselves: Urgent action needed for Coinbase investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 6.

Coinbase: Buy or sell? Read more here...

@ boerse-global.de | US19260Q1076 GOLDMAN

Weitere Meldungen

ANALYSE-FLASH: Goldman senkt Swiss Re auf 'Sell' - Ziel 121 Franken Die US-Investmentbank Goldman Sachs hat das Kursziel für Swiss Re CH0126881561 von 133 auf 121 Franken gesenkt und die Aktien von "Neutral" auf "Sell" abgestuft. (Boerse, 21.01.2026 - 08:35) weiterlesen...

ANALYSE-FLASH: Goldman senkt Douglas auf 'Neutral' - Ziel 13 Euro Die US-Investmentbank Goldman Sachs hat das Kursziel für Douglas nach den Eckdaten des ersten Geschäftsquartals von 15 auf 13 Euro gesenkt und die Aktien von "Buy" auf "Neutral" abgestuft. (Boerse, 20.01.2026 - 08:50) weiterlesen...

ANALYSE-FLASH: Goldman senkt Carl Zeiss Meditec auf 'Neutral' - Ziel 42 Euro Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec DE0005313704 von 54 auf 42 Euro gesenkt und die Aktien von "Buy" auf "Neutral" abgestuft. (Boerse, 20.01.2026 - 08:20) weiterlesen...

ANALYSE-FLASH: Goldman senkt FMC auf 'Neutral' - Ziel runter auf 40 Euro Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC DE0005785802 von 55 auf 40 Euro gesenkt und die Aktien von "Buy" auf "Neutral" abgestuft. (Boerse, 20.01.2026 - 08:05) weiterlesen...

ANALYSE-FLASH: Goldman hebt Roche auf 'Neutral' - Ziel 365 Franken Die US-Investmentbank Goldman Sachs hat das Kursziel für Roche CH0012032048 deutlich erhöht von 260 auf 365 Franken und die Aktien von "Sell" auf "Neutral" hochgestuft. (Boerse, 16.01.2026 - 09:50) weiterlesen...

Abschied von Apple Card hebt Gewinn von Goldman Sachs - Aktie verliert Die Abgabe des Geschäfts mit Apple-Kreditkarten US0378331005 an JPMorgan Case US46625H1005 hat der US-Investmentbank Goldman Sachs US38141G1040 Ende 2025 einen milliardenschweren Gewinnsprung eingebracht. (Boerse, 15.01.2026 - 15:26) weiterlesen...